The overall objective of the Viral Vector and Transgenic Mouse Core is to provide Diabetes Research Center affiliate investigators at the University of Washington with state-of-the-art vectors necessary to overexpress, knockdown, knockout, or otherwise alter expression of RNAs and proteins of interest in cultured cells, isolated fissues, and animals. The Core has considerably evolved since the last competifive renewal. New services to generate genetically engineered mice have been added, and under-ufilized and standard molecular biology methods that are now increasingly performed in individual investigator's labs have been removed.
The specific aims of the Core are to provide the following services to affiliate invesfigators: (1) Producfion of lentiviral, adenoviral and retroviral vectors for use in animals, fissues, and cells;(2) Producfion of vectors for generation of transgenic, knockout, and knockin mice;(3) Specialized molecular biology methods not routinely performed in affiliate investigators'laboratories;(4) Cost-effective production of genefically engineered mice through the University of Washington Transgenic Resources Program;and (5) Consultafion and training.. The Core has been highly productive in the current funding period and has added new services that are expected to significantly increase producfivity and usability for Diabetes Research Center affiliate investigators to meet the Center's goal to enhance research in diabetes, obesity and related disorders in the Greater Seattle area and beyond.

Public Health Relevance

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK017047-38
Application #
8635328
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$163,634
Indirect Cost
$69,592
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Ikizler, Halil O; Zelnick, Leila; Ruzinski, John et al. (2016) Dietary Acid Load is Associated With Serum Bicarbonate but not Insulin Sensitivity in Chronic Kidney Disease. J Ren Nutr 26:93-102
Tang, Chongren; Houston, Barbara A; Storey, Carl et al. (2016) Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages. J Lipid Res 57:848-57
Kanter, Jenny E; Bornfeldt, Karin E (2016) Impact of Diabetes Mellitus. Arterioscler Thromb Vasc Biol 36:1049-53
Ronsein, Graziella E; Hutchins, Patrick M; Isquith, Daniel et al. (2016) Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects. Arterioscler Thromb Vasc Biol 36:404-11
Neal, Adam S; Rountree, Austin M; Radtke, Jared R et al. (2016) A method for high-throughput functional imaging of single cells within heterogeneous cell preparations. Sci Rep 6:39319
Shimizu-Albergine, Masami; Van Yserloo, Brian; Golkowski, Martin G et al. (2016) SCAP/SREBP pathway is required for the full steroidogenic response to cyclic AMP. Proc Natl Acad Sci U S A 113:E5685-93
Aroda, Vanita R; Edelstein, Sharon L; Goldberg, Ronald B et al. (2016) Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab 101:1754-61
Rountree, Austin; Karkamkar, Amit; Khalil, Gamal et al. (2016) BaroFuse, a novel pressure-driven, adjustable-throughput perfusion system for tissue maintenance and assessment. Heliyon 2:e00210
Willard, Joshua R; Barrow, Breanne M; Zraika, Sakeneh (2016) Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels. Diabetologia :
Bornfeldt, Karin E (2016) Does Elevated Glucose Promote Atherosclerosis? Pros and Cons. Circ Res 119:190-3

Showing the most recent 10 out of 1030 publications